NewsVenture Capital17/09/2020
Finch Therapeutics announces Series D financing including Baupost
Baupost Group →Finch Therapeutics announced a Series D financing with Baupost among the new investors. The proceeds were designated for clinical development of oral microbiome therapies. This records the historical financing, not current ownership.